Hypertension
Hypertension affects one in three people on Earth. That figure, measured in 2024, represents roughly 1.4 billion human beings walking around with persistently elevated pressure in their arteries. And here is the part that makes that number truly alarming: nearly half of them have no idea. High blood pressure rarely announces itself. It produces no reliable pain, no obvious warning, no moment of crisis until, often, a stroke or a failing heart makes the damage undeniable. The World Health Organization has named it the leading cause of cardiovascular mortality on the planet. In 2019 alone, it was a contributing factor in an estimated 10.4 million deaths globally, accounting for 19% of all deaths that year. How did a condition so quiet become so deadly? What happens inside the body when pressure climbs too high? And why, despite a century of effective treatment, does so much of the world remain undiagnosed and untreated? Those are the questions this documentary will follow.
Stephen Hales, an English clergyman, made the first published measurement of blood pressure in 1733. What he was measuring was pressure: the force that blood exerts against the walls of the arteries with each beat of the heart. Blood pressure is recorded as two numbers. The first, systolic pressure, captures the peak force when the heart contracts. The second, diastolic pressure, measures the lower force between beats while the heart rests. For most adults, normal resting blood pressure sits below 120 mmHg systolic and 80 mmHg diastolic. When resting pressure climbs persistently to 130/80 mmHg or above, the classification enters Stage 1 hypertension. At 140/90 mmHg or above, Stage 2. The numbers become a map of accumulated mechanical stress on blood vessel walls, year after year. In the most established form of essential hypertension, cardiac output stays roughly normal while resistance to blood flow through peripheral vessels rises. Small arteries and arterioles narrow structurally over time, and that structural change is largely what makes the elevated pressure so persistent. In older adults, arterial stiffness adds another variable: the gap between systolic and diastolic pressure, called pulse pressure, widens. This produces a pattern called isolated systolic hypertension, where systolic readings run high while diastolic readings stay normal or even fall.
About 90 to 95% of hypertension cases carry no single identifiable cause. These are classified as primary, or essential, hypertension, and the science behind them is genuinely complex. More than 2,000 common genetic variants with small individual effects on blood pressure have been identified in research. Some rare genetic variants carry large effects. Beyond genetics, the body also accumulates environmental pressures. Blood pressure rises with age in societies following a western diet and lifestyle. Excess salt in the diet, excess body weight, physical inactivity, alcohol use, and smoking all increase risk. The mechanisms are multiple. Excessive sodium intake, or insufficient potassium, leads to higher intracellular sodium levels in vascular smooth muscle, which causes those muscles to contract and restrict blood flow. A subgroup called non-modulating essential hypertension, estimated at 25% of the hypertensive population, involves a specific salt-sensitive pattern where sodium intake fails to modulate the adrenal or renal vascular responses to angiotensin II. Depression and loneliness are each associated with hypertension. Periodontal disease is associated with high blood pressure, a connection the European Society of Cardiology guidelines also note. Arsenic exposure through drinking water and air pollution carry their own associations. Gout and elevated blood uric acid appear likely causal contributors, based on Mendelian Randomization studies and clinical trials. Average blood pressure is measurably higher in winter than in summer. Events as far back as birth matter too: low birth weight, maternal smoking during pregnancy, and lack of breastfeeding are each associated with higher blood pressure in adult life, though the strength of those relationships is described as weak.
Kidney disease is the most common identifiable cause of the remaining 5 to 10% of hypertension cases, those classified as secondary. The kidneys sit at the center of blood pressure regulation, and damage to them or their blood supply can drive pressure upward through multiple pathways. Renal artery stenosis, the narrowing of the arteries supplying the kidneys, whether from atherosclerosis or from a condition called fibromuscular dysplasia, is one such pathway. A physician examining a patient with renal artery stenosis may detect a localized abdominal bruit to the left or right of the midline. Cushing's syndrome, caused by excess cortisol, frequently produces not just high blood pressure but also truncal obesity, a distinctive hump of fat behind the neck and shoulders, and purple abdominal stretch marks. Pheochromocytoma, a tumor of the adrenal gland, may trigger abrupt episodes of hypertension alongside headache, palpitations, pale appearance, and excessive sweating. Primary aldosteronism turns out to be present in as many as one in five people whose hypertension resists treatment with multiple medications. That is notable because primary aldosteronism is, in many cases, a treatable and sometimes curable condition. Coarctation of the aorta, a structural narrowing of the main artery from the heart, typically produces a striking physical finding: decreased blood pressure in the lower limbs compared to the arms. Secondary hypertension in children is proportionally more common than in adults, and kidney disease accounts for most of those pediatric cases.
A systolic pressure at or above 180 mmHg, or a diastolic pressure at or above 120 mmHg, defines a hypertensive crisis. Two categories divide this emergency. Hypertensive urgency means the pressure has risen severely without evidence of active organ damage; oral medications are used to bring it down gradually over 24 to 48 hours. Hypertensive emergency is the more dangerous designation, present when direct damage to one or more organs is occurring. The brain, kidney, heart, and lungs are the organs most affected, and symptoms may include confusion, drowsiness, chest pain, and breathlessness. In pregnancy, a different version of crisis presents through pre-eclampsia, a serious condition in the second half of pregnancy marked by elevated blood pressure and protein in the urine. Pre-eclampsia occurs in about 5% of pregnancies and is responsible for roughly 16% of all maternal deaths globally. It also doubles the risk of death for the baby around the time of birth. In rare cases pre-eclampsia progresses to eclampsia, which carries the risk of vision loss, brain swelling, seizures, kidney failure, and a blood-clotting disorder called disseminated intravascular coagulation. One 2003 review measured the downstream arithmetic: reducing diastolic blood pressure by just 5 mmHg was associated with a 34% decrease in the risk of stroke, a 21% decrease in ischemic heart disease risk, and reduced likelihood of dementia, heart failure, and cardiovascular death.
Medieval Persian medical texts described a condition called fullness disease, with symptoms including headache, distended vessels, a full pulse, and hemorrhagic stroke, which scholars read as an early description of hypertensive crisis. Centuries before any blood pressure measurement existed, the Yellow Emperor of China, Cornelius Celsus, Galen, and Hippocrates all advocated reducing blood volume through bloodletting or leeches. Their dietary prescriptions included avoiding wine, meat, and pastries and eating spinach and vinegar. The cuff-based sphygmomanometer, invented by Scipione Riva-Rocci in 1896, gave clinicians their first practical tool to measure systolic pressure. In 1905, Nikolai Korotkoff described the sounds heard through a stethoscope when the cuff deflates, sounds now called the Korotkoff sounds, which allowed both systolic and diastolic pressure to be measured. The first chemical used against hypertension was sodium thiocyanate in 1900, but its side effects made it unpopular. In the decades after the Second World War, agents including tetramethylammonium chloride, hexamethonium, hydralazine, and reserpine (derived from the medicinal plant Rauvolfia serpentina) were used, but none were well tolerated. The genuine breakthrough arrived in 1958 with chlorothiazide, the first thiazide diuretic, developed from the antibiotic sulfanilamide. Beta blockers, calcium channel blockers, ACE inhibitors, angiotensin receptor blockers, and renin inhibitors followed, building the pharmacological toolkit that clinicians use today. The 2025 American Heart Association guidelines recommend medication for all adults with average blood pressure at or above 140/90 mmHg.
The American Heart Association estimated the direct and indirect costs of high blood pressure in the United States in 2010 at $76.6 billion. In the US, 80% of people with hypertension are aware of their condition, 71% take some medication, but only 48% of those who know they have it adequately control it. The gap between awareness and control is the operational problem. Lifestyle changes sit at the front line of both prevention and management. The evidence supports weight loss, dietary salt reduction to below 100 mmol per day, aerobic physical activity at moderate intensity for at minimum 150 minutes per week, limiting alcohol to no more than one drink per day for women and two for men, and a diet rich in whole grains, fruits, and vegetables, such as the DASH diet. A 2024 clinical guideline specifically recommended a minimum of 28 grams of dietary fiber per day for women and 38 grams per day for men with hypertension. A single lifestyle change can lower blood pressure as effectively as a single antihypertensive medication; combinations of two or more can do better still. Walking, a 2020 Cochrane review found, likely reduces systolic blood pressure across different age groups and both sexes. For those whose blood pressure remains resistant despite three or more medications, the condition has a name: resistant hypertension. Up to three concurrent medications, however, can control blood pressure in 90% of people when prescribed appropriately. The World Hypertension League, an umbrella organization of 85 national hypertension societies and leagues, has dedicated the 17th of May each year as World Hypertension Day since 2005, recognizing that more than half of the hypertensive population worldwide remains unaware of their condition.
Continue Browsing
Common questions
What is hypertension and what blood pressure level counts as high?
Hypertension is a long-term medical condition in which blood pressure in the arteries is persistently elevated. For most adults, Stage 1 hypertension begins at a resting blood pressure of 130/80 mmHg, and Stage 2 at 140/90 mmHg or above.
How many people worldwide have hypertension?
In 2024, an estimated one in three people globally, roughly 1.4 billion adults, had hypertension. In 1990, the comparable figure was about 650 million, with the rise driven largely by an aging population in low- and middle-income countries.
What causes hypertension in most people?
About 90 to 95% of hypertension cases are primary, or essential, hypertension, resulting from a combination of genetic factors and lifestyle influences including excess dietary salt, excess body weight, physical inactivity, smoking, and alcohol use. More than 2,000 common genetic variants with small individual effects on blood pressure have been identified.
What is a hypertensive crisis and when does it become an emergency?
A hypertensive crisis is a severely elevated blood pressure at or above 180 mmHg systolic or 120 mmHg diastolic. It becomes a hypertensive emergency when direct damage to organs such as the brain, kidney, heart, or lungs is occurring, producing symptoms including confusion, chest pain, and breathlessness.
What were the first effective medications used to treat hypertension?
The first chemical used against hypertension was sodium thiocyanate in 1900, but it had many side effects. The genuine breakthrough came in 1958 with chlorothiazide, the first thiazide diuretic, developed from the antibiotic sulfanilamide. Beta blockers, calcium channel blockers, and ACE inhibitors followed in subsequent decades.
How does hypertension affect pregnancy and what is pre-eclampsia?
Hypertension occurs in approximately 8 to 10% of pregnancies. Pre-eclampsia is a serious condition in the second half of pregnancy marked by elevated blood pressure and protein in the urine; it occurs in about 5% of pregnancies and accounts for roughly 16% of all maternal deaths globally. It also doubles the risk of death for the baby around the time of birth.
All sources
193 references cited across the entry
- 1BookMedical sciencesNaish J, Court DS — Elsevier Health Sciences — 2014
- 2About High Blood Pressure15 May 2024
- 3JournalGlobal burden of cardiovascular disease and stroke: hypertension at the coreDaniel T. Lackland et al. — May 2015
- 4BookGlobal atlas on cardiovascular disease prevention and controlMendis S, Puska P, Norrving B — World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization — 2011
- 5JournalTreatment options and considerations for hypertensive patients to prevent dementiaHernandorena I, Duron E, Vidal JS, Hanon O — July 2017
- 6JournalModifiable Risk Factors and Atrial FibrillationLau DH, Nattel S, Kalman JM, Sanders P — August 2017
- 7HypertensionWorld Health Organization (WHO) — 25 September 2025
- 8Journal2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesWhelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT — June 2018
- 9Journal2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC, Svetkey LP, Taler SJ, Townsend RR, Wright JT, Narva AS, Ortiz E — February 2014
- 10How Is High Blood Pressure Treated?10 September 2015
- 11JournalHypertensionPoulter NR, Prabhakaran D, Caulfield M — August 2015
- 12JournalPharmacotherapy for hypertension in adults 60 years or olderVijaya M. Musini — 2025-10-09
- 13JournalEffects of blood pressure reduction in mild hypertension: a systematic review and meta-analysisSundström J, Arima H, Jackson R, Turnbull F, Rahimi K, Chalmers J, Woodward M, Neal B — February 2015
- 14JournalEffects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysisXie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A — January 2016
- 15JournalHigher blood pressure targets for hypertension in older adultsJamie M. Falk et al. — 2024-12-17
- 16JournalPharmacotherapy for mild hypertensionWang D, Wright JM, Adams SP, Cundiff DK, Gueyffier F, Grenet G, Ambasta A — 24 September 2025
- 17JournalPharmacotherapy for hypertension in adults aged 18 to 59 yearsMusini VM, Gueyffier F, Puil L, Salzwedel DM, Wright JM — August 2017
- 18BookGlobal report on hypertension: the race against a silent killerWorld Health Organization (WHO) — 19 March 2023
- 19BookHarrison's Principles of Internal MedicineFisher ND, Williams GH — McGraw-Hill — 2005
- 20JournalLay perspectives on hypertension and drug adherence: systematic review of qualitative researchMarshall IJ, Wolfe CD, McKevitt C — July 2012
- 21JournalThe eye in hypertensionWong TY, Wong T, Mitchell P — February 2007
- 23BookABC of hypertensionO'Brien E, Beevers DG, Lip GY — BMJ Books — 2007
- 24High Blood Pressure – Understanding the Silent KillerU.S. Food and Drug Administration — 2021-01-21
- 25JournalHypertensive crisisRodriguez MA, Kumar SK, De Caro M — 2010-04-01
- 27JournalHypertensive crises: challenges and managementMarik PE, Varon J — June 2007
- 28JournalPharmacological interventions for hypertensive emergenciesPerez MI, Musini VM — January 2008
- 29BookHarrison's principles of internal medicine.McGraw-Hill — 2011
- 30JournalImpact of Chronic Hypertension and Antihypertensive Treatment on Adverse Perinatal Outcomes: Systematic Review and Meta-AnalysisAl Khalaf SY, O'Reilly ÉJ, Barrett PM, B Leite DF, Pawley LC, McCarthy FP, Khashan AS — May 2021
- 31JournalPregnancy complications increase the risk of heart attacks and stroke in women with high blood pressure2023-11-21
- 32JournalAssociation Between Chronic Hypertension and the Risk of 12 Cardiovascular Diseases Among Parous Women: The Role of Adverse Pregnancy OutcomesAl Khalaf S, Chappell LC, Khashan AS, McCarthy FP, O'Reilly ÉJ — July 2023
- 33Hypertension and PregnancyGibson P — Medscape — 30 July 2009
- 34JournalHypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart AssociationVesna D. Garovic et al. — February 2022
- 35JournalPhysical exercise in pregnancy: benefits, risks and prescriptionMaria Margarida Ribeiro et al. — 2022-01-27
- 36JournalExercise during pregnancy for preventing gestational diabetes mellitus and hypertensive disorders: An umbrella review of randomised controlled trials and an updated meta-analysisVicente Martínez-Vizcaíno et al. — February 2023
- 37JournalComparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trialsYuan-Hui Liu et al. — May 2023
- 38JournalEffects of aerobic exercise performed during pregnancy on hypertension and gestational diabetes: a systematic review and meta-analysisJuan Zhang et al. — July 2023
- 39HypertensionRodriguez-Cruz E, Ettinger LM — Medscape — 6 April 2010
- 40JournalGenome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traitsJacob M. Keaton et al. — May 2024
- 41JournalMolecular mechanisms of human hypertensionLifton RP, Gharavi AG, Geller DS — February 2001
- 42JournalTrans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylationKato N, Loh M, Takeuchi F, Verweij N, Wang X, Zhang W, etal — November 2015
- 43JournalThe western diet and lifestyle and diseases of civilizationCarrera-Bastos P, Fontes-Villalba M, O'Keefe JH, Lindeberg S, Cordain L — 2011-03-09
- 44JournalResidual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart StudyVasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D — February 2002
- 45JournalBlood Pressure Effects of Sodium Reduction: Dose–Response Meta-Analysis of Experimental StudiesTommaso Filippini et al. — 2021-04-20
- 46JournalWeight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart AssociationMichael E. Hall et al. — November 2021
- 47JournalExercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trialsJamie J. Edwards et al. — October 2023
- 48JournalEffects of Vegetarian Diets on Blood Pressure Lowering: A Systematic Review with Meta-Analysis and Trial Sequential AnalysisKai Wei Lee et al. — 2020-05-29
- 49JournalPotassium and Hypertension: A State-of-the-Art ReviewSriram Sriperumbuduri et al. — 2023-09-29
- 50JournalCalcium supplementation for prevention of primary hypertensionGabriela Cormick et al. — 2022-01-11
- 51JournalAlcohol Intake and Blood Pressure Levels: A Dose-Response Meta-Analysis of Nonexperimental Cohort StudiesSilvia Di Federico et al. — October 2023
- 52JournalThe effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysisMesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E — October 2011
- 53JournalVitamin D and hypertension: current evidence and future directionsVaidya A, Forman JP — November 2010
- 54JournalSeasonal variation in blood pressure: current evidence and recommendations for hypertension managementKeisuke Narita et al. — November 2021
- 55JournalDepression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studiesMeng L, Chen D, Yang Y, Zheng Y, Hui R — May 2012
- 56JournalLoneliness matters: a theoretical and empirical review of consequences and mechanismsHawkley LC, Cacioppo JT — October 2010
- 57JournalPeriodontitis is associated with hypertension: a systematic review and meta-analysisMuñoz Aguilera E, Suvan J, Buti J, Czesnikiewicz-Guzik M, Barbosa Ribeiro A, Orlandi M, Guzik TJ, Hingorani AD, Nart J, D'Aiuto F — January 2020
- 58JournalArsenic exposure and hypertension: a systematic reviewAbhyankar LN, Jones MR, Guallar E, Navas-Acien A — April 2012
- 59JournalGlobal association between ambient air pollution and blood pressure: A systematic review and meta-analysisYang BY, Qian Z, Howard SW, Vaughn MG, Fan SJ, Liu KK, Dong GH — April 2018
- 60JournalAssociation between serum urate, gout and comorbidities: a case–control study using data from the UK BiobankGabriela Sandoval-Plata et al. — 2021-07-01
- 61JournalUrate, Blood Pressure, and Cardiovascular Disease: Evidence From Mendelian Randomization and Meta-Analysis of Clinical TrialsDipender Gill et al. — February 2021
- 62JournalAssessing the Causal Relationships Between Insulin Resistance and Hyperuricemia and Gout Using Bidirectional Mendelian RandomizationNatalie McCormick et al. — November 2021
- 63JournalAssociations of Insulin Resistance With Systolic and Diastolic Blood Pressure: A Study From the HCHS/SOLOdayme Quesada et al. — September 2021
- 64JournalEarly life determinants of adult blood pressureLawlor DA, Smith GD — May 2005
- 65BookWilliams textbook of endocrinologyDluhy RG, Williams GH — W.B. Saunders — 1998
- 66JournalDrug-induced hypertension: an unappreciated cause of secondary hypertensionGrossman E, Messerli FH — January 2012
- 67JournalSex-Specific Associations Between Alcohol Consumption and Incidence of Hypertension: A Systematic Review and Meta-Analysis of Cohort StudiesRoerecke M, Tobe SW, Kaczorowski J, Bacon SL, Vafaei A, Hasan OS, Krishnan RJ, Raifu AO, Rehm J — June 2018
- 68JournalHemodynamic aspects of essential hypertension in humansConway J — April 1984
- 69JournalThe role of cardiac autonomic function in hypertension and cardiovascular diseasePalatini P, Julius S — June 2009
- 70JournalPrediction of future hypertension by casual blood pressure or invasive hemodynamics? A 30-year follow-up studyAndersson OK, Lingman M, Himmelmann A, Sivertsson R, Widgren BR — 2004
- 71JournalPhysiological aspects of primary hypertensionFolkow B — April 1982
- 72JournalThe microcirculation and hypertensionStruijker Boudier HA, le Noble JL, Messing MW, Huijberts MS, le Noble FA, van Essen H — December 1992
- 73JournalReactivity of small blood vessels in hypertension: relation with structural changes. State of the art lectureSchiffrin EL — February 1992
- 74JournalArterial and venous compliance in sustained essential hypertensionSafar ME, London GM — August 1987
- 75JournalHigher heart rate variability as a predictor of atrial fibrillation in patients with hypertensioneKim SH, Lim KR, Chun KJ — 2022
- 76JournalVascular stiffness and increased pulse pressure in the aging cardiovascular systemSteppan J, Barodka V, Berkowitz DE, Nyhan D — 2011-08-02
- 77JournalClinical practice. Isolated systolic hypertension in the elderlyChobanian AV — August 2007
- 78JournalMechanisms, pathophysiology, and therapy of arterial stiffnessZieman SJ, Melenovsky V, Kass DA — May 2005
- 79JournalCounterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertensionNavar LG — December 2010
- 80JournalPoint: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertensionEsler M, Lambert E, Schlaich M — December 2010
- 81JournalEndothelium-dependent contractions and endothelial dysfunction in human hypertensionVersari D, Daghini E, Virdis A, Ghiadoni L, Taddei S — June 2009
- 82JournalRole of the renin-angiotensin system in vascular inflammationMarchesi C, Paradis P, Schiffrin EL — July 2008
- 83JournalTargeting the immune system to treat hypertension: where are we?Gooch JL, Sharma AC — September 2014
- 84JournalSodium and potassium in the pathogenesis of hypertensionAdrogué HJ, Madias NE — May 2007
- 85JournalSodium-to-potassium ratio and blood pressure, hypertension, and related factorsPerez V, Chang ET — November 2014
- 86JournalNon-modulating essential hypertension: a subset particularly responsive to converting enzyme inhibitorsWilliams GH, Hollenberg NK — November 1985
- 87BookHarrison's Principles of Internal MedicineMcGraw-Hill Education — 2018
- 88JournalScreening for Hypertension and Lowering Blood Pressure for Prevention of Cardiovascular Disease EventsViera AJ — July 2017
- 89BookHypertension: From basic research to clinical practiceVischer AS, Burkard T — 2017
- 90JournalScreening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statementSiu AL — November 2015
- 91BookHypertension (NICE CG 127)National Clinical Guidance Centre — National Institute for Health and Clinical Excellence — August 2011
- 92JournalUnusual hypertensive phenotypes: what is their significance?Franklin SS, Wilkinson IB, McEniery CM — February 2012
- 93JournalOrthostatic hypertension: a measure of blood pressure variation for predicting cardiovascular riskKario K — June 2009
- 94JournalHypertension in children and adolescentsLuma GB, Spiotta RT — May 2006
- 95BookGuideline for the pharmacological treatment of hypertension in adultsWorld Health Organization (WHO) — 2021
- 96JournalSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureChobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ — December 2003
- 97JournalHarmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension GuidelinesPaul K Whelton et al. — 2022-09-14
- 98Journal2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO)John William McEvoy et al. — 2024-08-30
- 99Journal2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. — 2023-12-01
- 100JournalHypertension in infancy: diagnosis, management and outcomeDionne JM, Abitbol CL, Flynn JT — January 2012
- 101JournalThe fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescentsNational High Blood Pressure Education Program Working Group on High Blood Pressure in Children Adolescents — August 2004
- 102JournalGuidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IVWilliams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, McG Thom S — March 2004
- 103JournalEvidence-based policy for salt reduction is neededJuly 2016
- 104JournalAssociations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studiesMente A, O'Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Li W, Lu Y, Yi S, Rensheng L, Iqbal R, Mony P, Yusuf R, Yusoff K, Szuba A, Oguz A, Rosengren A, Bahonar A, Yusufali A, Schutte AE, Chifamba J, Mann JF, Anand SS, Teo K, Yusuf S — July 2016
- 105JournalEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F — July 2012
- 106JournalScreening for elevated blood pressure in children and adolescents: a critical appraisalChiolero A, Bovet P, Paradis G — March 2013
- 107JournalBlood pressure screening in children and adolescents: is the glass half empty or more than half full?Daniels SR, Gidding SS — March 2013
- 108JournalScreening strategies for hypertensionSchmidt BM, Durao S, Toews I, Bavuma CM, Hohlfeld A, Nury E, Meerpohl JJ, Kredo T — May 2020
- 109JournalExpert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary reportDecember 2011
- 111JournalScreening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statementMoyer VA — November 2013
- 113JournalScreening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation StatementKrist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB — April 2021
- 114JournalLowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategyLaw M, Wald N, Morris J — 2003
- 115JournalThe 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertensionDaskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, etal — May 2015
- 117JournalBlood pressure targets for hypertension in people with diabetes mellitusArguedas JA, Leiva V, Wright JM — October 2013
- 118JournalBlood pressure targets for the treatment of people with hypertension and cardiovascular diseaseSaiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, Leache L — November 2022
- 119JournalBlood pressure targets in adults with hypertensionArguedas JA, Leiva V, Wright JM — December 2020
- 120JournalPharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family PhysiciansQaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA — March 2017
- 121JournalEvidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority viewWright JT, Fine LJ, Lackland DT, Ogedegbe G, Dennison Himmelfarb CR — April 2014
- 122JournalHypertension Management in Diabetes: 2018 UpdatePasquale Passarella et al. — 2018-08-01
- 123JournalKDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseAlfred K. Cheung et al. — March 2021
- 124JournalLower blood pressure targets: to whom do they apply?Brunström M, Carlberg B — January 2016
- 125JournalIntensive blood pressure lowering – Authors' replyXie X, Atkins E, Lv J, Rodgers A — June 2016
- 126Journal2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesJones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, et al. — 16 September 2025
- 127JournalAn effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and PreventionGo AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, Sanchez E — April 2014
- 128JournalLong-term effects of weight-reducing diets in people with hypertensionSemlitsch T, Krenn C, Jeitler K, Berghold A, Horvath K, Siebenhofer A — February 2021
- 129JournalEffect of longer-term modest salt reduction on blood pressureHe FJ, Li J, Macgregor GA — April 2013
- 130JournalEffect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trialsHuang L, Trieu K, Yoshimura S, Neal B, Woodward M, Campbell NR, Li Q, Lackland DT, Leung AA, Anderson CA, MacGregor GA, He FJ — February 2020
- 131JournalEffects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research GroupSacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH — January 2001
- 132JournalEfficacy of different dietary patterns on lowering of blood pressure level: an umbrella reviewSukhato K, Akksilp K, Dellow A, Vathesatogkit P, Anothaisintawee T — December 2020
- 133JournalPlant-Based Diets and HypertensionJoshi S, Ettinger L, Liebman SE — 2020
- 134JournalLifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of HypertensionCharchar FJ, Prestes PR, Mills C — 2024
- 135JournalRecommendations for the Use of Dietary Fiber to Improve Blood Pressure ControlJama, HA, Snelson M, Schutte AE — 2024
- 136JournalEffect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analysesAburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP — April 2013
- 137JournalPotassium Intake, Bioavailability, Hypertension, and Glucose ControlStone MS, Martyn L, Weaver CM — July 2016
- 139JournalHyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockersRaebel MA — June 2012
- 140JournalBeyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart associationBrook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisognano JD, Elliott WJ, Fuchs FD, Hughes JW, Lackland DT, Staffileno BA, Townsend RR, Rajagopalan S — June 2013
- 141JournalWalking for hypertensionLou Y, Ye G, Liu W, Lv Z, Jia Y, Li C, Zhang Y — February 2021
- 142JournalClinical effectiveness of stress-reduction techniques in patients with hypertension: systematic review and meta-analysisNagele E, Jeitler K, Horvath K, Semlitsch T, Posch N, Herrmann KH, Grouven U, Hermanns T, Hemkens LG, Siebenhofer A — October 2014
- 143JournalRelaxation therapies for the management of primary hypertension in adultsDickinson HO, Campbell F, Beyer FR, Nicolson DJ, Cook JV, Ford GA, Mason JM — January 2008
- 144JournalInterventions used to improve control of blood pressure in patients with hypertensionGlynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T — March 2010
- 145JournalFirst-line drugs for hypertensionWright JM, Musini VM, Gill R — April 2018
- 146JournalBlood pressure lowering efficacy of diuretics as second-line therapy for primary hypertensionChen JM, Heran BS, Wright JM — October 2009
- 147JournalFirst-line combination therapy versus first-line monotherapy for primary hypertensionGarjón J, Saiz LC, Azparren A, Gaminde I, Ariz MJ, Erviti J — February 2020
- 148JournalWithdrawal of antihypertensive drugs in older peopleDanijela Gnjidic — 2025-03-31
- 149JournalBeta-blockers for hypertensionWiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH — January 2017
- 150JournalPharmacological interventions for hypertension in childrenChaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R — February 2014
- 151JournalManagement of Resistant Hypertension-An UpdateGiacona JM, Kositanurit W, Vongpatanasin W — April 2024
- 152Journal2024 ESC Guidelines for the management of elevated blood pressure and hypertensionJohn William McEvoy et al. — 2024-10-07
- 153JournalElectronic monitors of drug adherence: tools to make rational therapeutic decisionsSantschi V, Chiolero A, Burnier M — November 2009
- 154JournalResistant hypertension: underlying causes and treatmentSarwar MS, Islam MS, Al Baker SM, Hasnat A — May 2013
- 155JournalDiagnosis and treatment of primary aldosteronism: practical clinical perspectivesYoung WF — February 2019
- 156JournalAutonomic-immune-vascular interaction: an emerging concept for neurogenic hypertensionZubcevic J, Waki H, Raizada MK, Paton JF — June 2011
- 157JournalBaroreceptors in the carotid and hypertension-systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressureWallbach M, Koziolek MJ — September 2018
- 158JournalTreatment of resistant and refractory hypertensionAcelajado MC, Hughes ZH, Oparil S, Calhoun DA — March 2019
- 159JournalRefractory hypertension: A novel phenotype of antihypertensive treatment failureDudenbostel T, Siddiqui M, Oparil S, Calhoun DA — June 2016
- 160JournalWorldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participantsMajid Ezzati et al. — 2021-09-11
- 161JournalSocioeconomic status and hypertension: a meta-analysisBing Leng et al. — February 2015
- 162JournalDiabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular MechanismsPetrie JR, Guzik TJ, Touyz RM — May 2018
- 163JournalPrevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D — March 1995
- 164JournalTrends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S — July 2007
- 165JournalElevated hypertension risk for African-origin populations in biracial societies: Modeling the Epidemiologic Transition StudyR. S. Cooper et al. — 2015
- 166JournalEpidemiological issues are not simply black and whiteFrohlich ED — October 2011
- 167JournalHypertension in children and adolescents: epidemiology and natural historyFalkner B — July 2010
- 168JournalHypertension in children and adolescentsLuma GB, Spiotta RT — May 2006
- 169Global health risks: mortality and burden of disease attributable to selected major risksWorld Health Organization — 2009
- 170JournalAge-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLewington S, Clarke R, Qizilbash N, Peto R, Collins R — December 2002
- 171JournalManagement of hypertension in peripheral arterial disease: does the choice of drugs matter?Singer DR, Kite A — June 2008
- 172JournalHistorical trends and milestones in hypertension research: a model of the process of translational researchKotchen TA — October 2011
- 173BookA century of arterial hypertension 1896–1996Wiley — 1996
- 174JournalThe medieval origins of the concept of hypertensionHeydari M, Dalfardi B, Golzari SE, Habibi H, Zarshenas MM — July 2014
- 175JournalAvicenna's doctrine about arterial hypertensionEmtiazy M, Choopani R, Khodadoost M, Tansaz M, Dehghan S, Ghahremani Z — 2014
- 176BookManual of hypertensionBlackwell Science — 1995
- 177JournalDeterminants of Isolated Systolic HypertensionSpencer Van B. Wilking — 1988-12-16
- 178Journal1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting.1993
- 179JournalFrom blood pressure to hypertension: the history of researchEsunge PM — October 1991
- 180JournalControlling hypertension. A research success storyDustan HP, Roccella EJ, Garrison HH — September 1996
- 181JournalExperiences with tetraethylammonium chloride in hypertensionLyons HH, Hoobler SW — February 1948
- 182JournalThe evolution of antihypertensive therapy: an overview of four decades of experienceBakris GL, Frohlich ED — December 1989
- 183JournalBenzothiadiazine dioxides as novel diureticsNovello FC, Sprague JM — 1957
- 184JournalTrends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ — July 1995
- 185JournalImpact of World Hypertension DayChockalingam A — May 2007
- 186JournalWorld Hypertension Day and global awarenessChockalingam A — June 2008
- 187JournalHeart disease and stroke statistics – 2010 update: a report from the American Heart AssociationLloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al — February 2010
- 188JournalHypertension, a health economics perspectiveAlcocer L, Cueto L — June 2008
- 189JournalThe economic impact of hypertensionElliott WJ — October 2003
- 190JournalEconomic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)Coca A — 2008
- 191BookGlobal report on hypertension 2025: high stakes – turning evidence into actionWorld Health Organization (WHO) — 23 September 2025
- 192JournalISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in CatsTaylor SS, Sparkes AH, Briscoe K, Carter J, Sala SC, Jepson RE, Reynolds BS, Scansen BA — March 2017
- 193JournalACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and catsAcierno MJ, Brown S, Coleman AE, Jepson RE, Papich M, Stepien RL, Syme HM — November 2018